TRVLX | VIVAX | TRVLX / VIVAX | |
Total Expense Ratio | 0.71 | 0.17 | 418% |
Annual Report Gross Expense Ratio | 0.72 | 0.17 | 424% |
Fund Existence | 31 years | 33 years | - |
Gain YTD | -0.045 | -3.426 | 1% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 2500 | 3000 | 83% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 28.7B | 191B | 15% |
Annual Yield % from dividends | 1.15 | 2.14 | 54% |
Returns for 1 year | -1.77 | 3.39 | -52% |
Returns for 3 years | 3.19 | 12.71 | 25% |
Returns for 5 years | 53.59 | 69.89 | 77% |
Returns for 10 years | 37.88 | 92.45 | 41% |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
MTUM | 204.82 | 4.49 | +2.24% |
iShares MSCI USA Momentum Factor ETF | |||
HQH | 16.13 | 0.35 | +2.22% |
abrdn Healthcare Investors | |||
MMD | 14.50 | 0.26 | +1.83% |
NYLI MacKay DefinedTerm Muni Opportunities Fund | |||
PWS | 30.76 | 0.01 | +0.04% |
Pacer WealthShield ETF | |||
JLS | 17.93 | -0.08 | -0.44% |
Nuveen Mortgage and Income Fund |